(Q40426276)

English

Recombinant murine interleukin-12 elicits potent antileukemic immune responses in a murine model of Philadelphia chromosome-positive acute lymphoblastic leukemia

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Recombinant murine interleukin-12 elicits potent antileukemic immune responses in a murine model of Philadelphia chromosome-positive acute lymphoblastic leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

based on heuristic

inferred from title

Philadelphia chromosome

1 reference

object named as

Philadelphia chromosome

2 August 2024

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Tanja A Gruber

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Dianne C Skelton

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

818-824

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700839

21 January 2018

GM-CSF-secreting melanoma vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700839

21 January 2018

Immune response to Philadelphia chromosome-positive acute lymphoblastic leukemia induced by expression of CD80, interleukin 2, and granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700839

21 January 2018

Combination of CD80 and granulocyte-macrophage colony-stimulating factor coexpression by a leukemia cell vaccine: preclinical studies in a murine model recapitulating Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700839

21 January 2018

Requirement for NK cells in CD40 ligand-mediated rejection of Philadelphia chromosome-positive acute lymphoblastic leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700839

21 January 2018

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700839

21 January 2018

Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700839

21 January 2018

Acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700839

7 January 2021

based on heuristic

inferred from DOI database lookup

Approaches for immunotherapy of lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700839

7 January 2021

based on heuristic

inferred from DOI database lookup

The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700839

7 January 2021

based on heuristic

inferred from DOI database lookup

Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700839

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700839

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700839

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40426276&oldid=2218907025"